Anna Rutkowska
GlaxoSmithKline (Germany)(DE)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Lipoproteins and Cardiovascular Health, Cancer, Lipids, and Metabolism, Biosimilars and Bioanalytical Methods, Health Systems, Economic Evaluations, Quality of Life
Most-Cited Works
- → Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis(2018)223 cited
- → Molecular mechanism and structure of Trigger Factor bound to the translating ribosome(2008)169 cited
- → Click chemistry enables preclinical evaluation of targeted epigenetic therapies(2017)141 cited
- → Association of condensin with chromosomes depends on DNA binding by its HEAT-repeat subunits(2014)115 cited
- → Functional Dissection of Escherichia coli Trigger Factor: Unraveling the Function of Individual Domains(2004)89 cited
- → A Modular Probe Strategy for Drug Localization, Target Identification and Target Occupancy Measurement on Single Cell Level(2016)85 cited
- → A Rapidly Reversible Chemical Dimerizer System to Study Lipid Signaling in Living Cells(2014)83 cited
- → Large‐scale purification of ribosome‐nascent chain complexes for biochemical and structural studies(2009)52 cited
- → Protein Tango: The Toolbox to Capture Interacting Partners(2012)46 cited
- → Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells(2024)45 cited